Muutke küpsiste eelistusi

E-raamat: Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond

  • Formaat: PDF+DRM
  • Ilmumisaeg: 23-Jul-2020
  • Kirjastus: John Wiley & Sons Inc
  • Keel: eng
  • ISBN-13: 9781119755760
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 22,42 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: PDF+DRM
  • Ilmumisaeg: 23-Jul-2020
  • Kirjastus: John Wiley & Sons Inc
  • Keel: eng
  • ISBN-13: 9781119755760
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

How the data revolution is transforming biotech and healthcare—and why you can’t afford to let it pass you by

We are living through a time when the digitization of health and medicine is becoming a reality, with new abilities to improve outcomes for patients as well as the efficiency and success of the organizations that serve them. In The Patient Equation, Glen de Vries presents the history and current state of life sciences and healthcare as well as crucial insights and strategies to help scientists, physicians, executives, and patients survive and thrive in the current disruptive, tech-driven landscape. The biggest challenge facing biotech, pharma, and medical device companies today is how to integrate new knowledge, new data, and new technologies to get the right treatments to the right patients at precisely the right times. This book shows you how to meet that challenge and embrace the data revolution. 

Drawing on the fascinating stories of businesses and individuals that are already making inroads—from a fertility-tracking bracelet changing the game for couples looking to get pregnant, to an entrepreneur reinventing the treatment of diabetes, to Medidata’s own work bringing clinical trials into the 21st century—de Vries shares the breakthroughs, approaches, and practical business techniques that allow companies to stay ahead of the curve and to deliver solutions faster, cheaper, and more successfully—while still upholding the principles of traditional therapeutic medicine.   

  • How one rare disease is leading the way for new approaches to understanding precision medicine
  • What it means to build robust, effective disease management platforms
  • Why value-based reimbursement is changing the business of life sciences
  • How the right alignment of incentives will improve outcomes at every stage of the patient journey 

Whether you’re a scientist, physician, or executive, you can’t afford to let the data revolution pass you by: understand the landscape with this must-read roadmap for success—and see how you can change the future of healthcare for the better.  

Introduction vii
SECTION 1 From Hippocrates to Epocrates
1(56)
Chapter 1 Before We Cured Scurvy
3(14)
Chapter 2 Inside The Equations
17(26)
Chapter 3 Fitbits, Smart Toilets, And A Bluetooth-Enabled Self-Driving Ecg
43(14)
SECTION 2 Applying Data to Disease
57(56)
Chapter 4 Ava---Tracking Fertility, On The Road Toward Understanding All Of Women's Health
59(10)
Chapter 5 One Breath, One Drop---Asthma And Diabetes, Chronic Conditions Being Conquered With Technology
69(12)
Chapter 6 Flumoji And Sepsis Watch---Two Approaches To Predicting And Preventing Acute, Life-Threatening Conditions Through Smarter Data
81(12)
Chapter 7 Cancer And Phage Therapy---Crafting Custom Treatments Just For You
93(12)
Chapter 8 Castleman Disease---Not One Rare Disease With No Treatments, But Three Rare Diseases ... With Hope, Thanks To Data
105(8)
SECTION 3 Building Your Own Patient Equations
113(78)
Chapter 9 The Steam Table
115(18)
Chapter 10 Good Data
133(10)
Chapter 11 Changing Clinical Trials
143(32)
Chapter 12 Disease Management Platforms
175(16)
SECTION 4 Scaling Progress to the World
191(58)
Chapter 13 The Importance Of Collaboration
193(10)
Chapter 14 Value-Based Reimbursement
203(14)
Chapter 15 Aligning Incentives
217(14)
Chapter 16 And Then, A Pandemic
231(18)
Conclusion 249(10)
Acknowledgments 259(2)
About the Authors 261(2)
Index 263
GLEN DE VRIES is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world. Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records. In 2019, in one of the largest health care technology acquisitions in history, Medidata became part of Dassault Systèmes. Glen has been driving Medidata's mission since the company's inception in 1999, "powering smarter treatments and healthier people" by advancing pharmaceutical business transformation with technology, non-traditional ways of thinking, and industry collaboration. Glen's work has appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics, and other journals. He also serves as a trustee of Carnegie Mellon University.

JEREMY BLACHMAN is a writer who works with leaders across industries on getting their ideas out to the world. He has published two novels and developed television pilots for NBC. His writing has appeared in The New York Times, The Wall Street Journal, and many other prominent publications.